Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Processa Pharmaceuticals Inc (NQ: PCSA ) 1.670 +0.009 (+0.53%) Streaming Delayed Price Updated: 3:37 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Processa Pharmaceuticals Inc < Previous 1 2 3 4 5 6 7 8 Next > InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Q2 2022 Results, Corporate Updates August 12, 2022 Via Investor Brand Network Exposures Product Safety Earnings Scheduled For August 11, 2022 August 11, 2022 Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. Via Benzinga InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Q2 2022 Results Conference Call August 08, 2022 Via Investor Brand Network Exposures Product Safety Earnings Scheduled For November 11, 2021 November 11, 2021 Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape... Via Benzinga InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Launches New Website Focused on Rare Disease August 04, 2022 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) CEO to Present at World Orphan Drug Congress USA July 12, 2022 Via Investor Brand Network Exposures Product Safety 41 Stocks Moving In Tuesday's Mid-Day Session June 14, 2022 Gainers Revlon, Inc. (NYSE: REV) rose 125.5% to $2.6499. Revlon’s stock dropped sharply on Monday after the company is reportedly expected to file for bankruptcy. Via Benzinga 82 Biggest Movers From Yesterday June 15, 2022 Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tuesday. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session May 20, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday May 17, 2022 On Tuesday, 123 stocks made new 52-week lows. Via Benzinga InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Q1 2022 Report, Updates May 13, 2022 Via Investor Brand Network Exposures Product Safety Preview: Processa Pharmaceuticals's Earnings May 11, 2022 Processa Pharmaceuticals (NASDAQ:PCSA) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Host Conference Call to Discuss Q1 2022 Results, Provide Drug Development Update May 05, 2022 Via Investor Brand Network Exposures Product Safety Earnings Scheduled For May 12, 2022 May 12, 2022 Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter. Via Benzinga 99 Biggest Movers From Yesterday May 12, 2022 Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company. Via Benzinga 90 Biggest Movers From Yesterday May 10, 2022 Gainers Via Benzinga InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Administers First Dosage in Amended Phase 1B Study April 20, 2022 Via Investor Brand Network InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Enrolls First Patient in PCS12852 Phase 2A Trial April 05, 2022 Via Investor Brand Network Processa Pharmaceuticals Earnings Preview March 29, 2022 Processa Pharmaceuticals (NASDAQ:PCSA) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2022 April 19, 2022 Upgrades Via Benzinga InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Host Conference Call to Discuss Q4 2021 Results, Provide Clinical Pipeline Update March 23, 2022 Via Investor Brand Network Earnings Scheduled For March 30, 2022 March 30, 2022 Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021. Via Benzinga InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Issues Letter to Shareholders Eyeing ‘Transformative Year’ in 2022 January 26, 2022 Via Investor Brand Network InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Q3 2021 Financial, Corporate Results November 12, 2021 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Results of Next-Generation Capecitabine Analysis November 04, 2021 Via Investor Brand Network Exposures Product Safety Processa Pharmaceuticals Inc. to Host Q3 Results, Development Update Call October 26, 2021 Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients with unmet... Via Benzinga InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Host Q3 Results, Development Update Call October 26, 2021 Via Investor Brand Network InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Key Milestone in Clinical Develop Program for PCS12852 October 12, 2021 Via Investor Brand Network Exposures Product Safety Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2021 August 03, 2021 Upgrades For SolarEdge Technologies Inc (NASDAQ: Via Benzinga Earnings Scheduled For August 12, 2021 August 12, 2021 Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS... Via Benzinga < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.